In addition, it is anticipated that the ACE2-RGF could encode unique insights about pathophysiologic information common to LUAD and COVID-19 and may serve as a biomarker for COVID-19 classification and the identification of critical illness. This evidence concerns the gene ACE2 and COVID-19.